Sonkar, Kumar, Nagayach, and Srivastava: Malignant mixed germ cell tumours- A rare case report with unusual presentation in a 05 years old female child


Introduction

Globally ovarian cancer accounts for 2,25,000 new cases and 1,40,000 deaths occurs annually.1 Malignant germ cell tumours (GCT) of ovary, an uncommon neoplasm originates from the primitive germ cells of embryonic gonad. Mostly they occur in the second and third decade of life and accounts for 2–3% of all ovarian neoplasms.2 The survival rates for germ cell tumours have dramatically improved for the past three decades coincident with more aggressive surgical staging and combination therapy.3 World Health Organization (1973) has classified malignant germ cell tumours as endodermal sinus tumour (yolk sac tumour), immature teratoma and dysgerminoma, non-gestational choriocarcinoma, embryonal carcinoma, and mixed germ cell type.4 Malignant mixed germ cell tumour is a type of tumour which consists of two or more malignant germ cell components. These tumours are rare cancers, which are seen in 8% cases of germ cell tumours but are very aggressive in nature.5 The Endodermal Sinus Tumour (EST) and dysgerminoma are the most common combination reported in the literature6 and the embryonal carcinoma and immature teratoma are the rarest combination as its components.4 Embryonal carcinoma, although very rare, but it holds the very malignant potential.7 In review of literatures, teratoma is the most common histology encountered followed by the dysgerminoma.3

Case Report

A 5-years old female child presented to the surgery department with a brief history of difficulty in defecation for 6 months, swelling over sacral region for 2 months, along with bilateral inguinal swellings and difficulty in urination for 1 week. On physical examination swelling was firm, non-mobile & non-tender measuring 6.6x5 cm (Figure 1 a & 1b). Complete blood counts, Liver function tests and Kidney function tests were within normal limit. Ultrasound was suggestive of heterogenous mass in sacral region, bilateral inguinal lymphadenopathy. MRI findings revealed a large solid presacral and pre-coccygeal mass lesion with pelvic extension, inguinal lymphadenopathy with mass effect and extension, suggestive of sacrococcygeal teratoma (Type III). Serum alfa fetoprotein (AFP) level was 39773.80 ng/ml. FNAC from sacral mass & bilateral inguinal swelling revealed high cellularity, comprising of neoplastic cells arranged in solid sheets, papillaroid fragments loose clusters and scattered singly. Individual tumour cells have high N:C ratio, with oval to elongated nuclei with coarse chromatin, moderate amount of vacuolated cytoplasm. At places eosinophilic material is also seen within the cell clusters (Figure 2 a & b). Cytological features were suggestive of malignant germ cell tumour of ovary. Excisional biopsy was done and sent for histopathological examination to our department. On gross examination, multiple greyish white pieces of tissue were received, altogether measuring 4x3x1 cm. Microscopically, multiple sections examined showed tumour arranged in reticular pattern. These tumour cells showed vesicular nuclei with moderate pleomorphism (Figure 3 c). Perivascular arrangement of tumour cells was also seen (Schiller-Duval bodies) (Figure 3 d). Some areas showed papillary and glandular differentiation (Figure 1 a). Some areas also showed undifferentiated primitive cells having hyperchromatic nuclei with course chromatin and occasional giant cells. Small focus of necrosis also noted (Figure 3 b). Lymphoid tissue was also identified infiltrated by tumour cells as described above. IHC stain shows cytoplasmic positivity for AFP and Pancytokeratin (Figure 4 a & b). Histopathological features were suggestive of malignant mixed germ cell tumour (predominantly yolk sac tumour (>90%) and embryonal carcinoma (<10%), metastasizing into the inguinal lymph nodes. Patient was treated with combination chemotherapy (cisplatin, etoposide and bleomycin) and she responded to the treatment. Then she was planned for debulking surgery.

Figure 1

Sacral swelling with skin discoloration (a): along with bilateral inguinal swellings (b)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/55b784e6-6233-4270-9fa6-97668ff84c9bimage1.png

Figure 2

Cellular smears showing solid sheets, papillaroid fragment, loose clusters and singly scattered cells (FNAC, MGG 100X (a), 400X (b)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/55b784e6-6233-4270-9fa6-97668ff84c9bimage2.png

Figure 3

Section examined showing papillary and glandular differentiation along with foci of necrosis (H&E, 40x) (a), Embryonal component showing primitive cells and necrotic area, (H&E, 400x) (b), Yolk sac component showing reticular areas (H&E, 100x) (c), Schiller-Duval body (H&E, 100x) (d)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/55b784e6-6233-4270-9fa6-97668ff84c9bimage3.png

Figure 4

a: AFP positivity; b: Cytokeratin positivity (IHC, 400X)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/55b784e6-6233-4270-9fa6-97668ff84c9bimage4.png

Discussion

The rare combination of uncommon germ cell components, large sacral mass with bilateral inguinal lymphadenopathy, and very high levels of tumour markers makes this case unusual. The germ cell tumour generally present at an average age of 13.8 years (4–27 years).8 Most commonly patient presents with complaint of abdominal mass which may be associated with or without abdominal pain or fever. Embryonal carcinoma can also present with precocious puberty or irregular vaginal bleeding as it may secrete estrogen.9 Immunohistochemistry is a widely used for the confirmation of diagnosis and to find new management modalities.10, 11 Yolk sac tumour shows positivity for AFP, Glypican-3, SALL4 and LIN 28, whereas in embryonal carcinoma tumour cells are positive for CK (AE1/AE3), CD30, OCT4, SALL4 and Glypican-3.12 Trinh DT et al. has described the utility of tumour markers CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in the malignant germ cell tumours of ovary.11 Ovarian endodermal sinus tumours are highly aggressive but with surgery and combination chemotherapy, the five-year survival with stage 1 tumours and more advanced disease are 92% and 29% to 44% respectively.13 Survival in embryonal carcinoma the first reported series of 15 patients was 39%, with 50% of stage I patients being disease free at 3.75 to 15 years post-surgery and chemotherapy.14 More recent data illustrate the conservative surgery and combination chemotherapy improves the survival, with survival rates of 98% and 94% for early and advanced stage tumours.15 Elevation of both AFP and hCG levels is a strong predictor of poor outocome.16 Kumar et al. suggested lymph node involvement as an independent predictor of poor survival.17 Pectasides et al. declared that if tumour appears to be confined to ovaries or pelvis, a pelvic and para-aortic lymphadenectomy should also be performed. If upper abdominal involvement is there, an effort to remove all visible tumour should be made. Also, in view of the excellent chemosensitivity, clinical judgment can be used if surgical management would significantly increase postoperative morbidity.18 If infertility is concerned than unilateral oophorectomy and surgical staging is the minimal surgery in ovarian germ cell tumour. Preservation of fertility is recommended even in metastatic disease as these tumours are highly sensitive to chemotherapy. Outcome cannot be changed by hysterectomy and bilateral salpingioophorectomy.10

Conclusion

Ovarian germ cell tumours arise from primordial germ cell derived from the embryonal gonads. Debulking surgery and combination chemotherapy is the mainstay in treatment of ovarian cancer.

Conflicts of Interest

All contributing authors declare no conflicts of interest.

Source of Funding

None.

References

1 

J Ferlay HR Shin F Bray D Forman C Mathers DM Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCANInt J Cancer2008127122893917

2 

JT Quirk N Natarajan Ovarian cancer incidence in the United States, 1992–1999Gynecol Oncol20059725192310.1016/j.ygyno.2005.02.007

3 

HO Smith M Berwick CF Verschraegen C Wiggins L Lansing CY Muller Qualis CR (2006) Incidence and survival rates for female malignant germ cell tumorsObstet Gynecol20051075107585

4 

M Koshy A Vijayananthan V Vadiveloo Malignant ovarian mixed germ cell tumour: a rare combinationBiomed Imaging Interv J200512e10

5 

A Munemane M Munemane Malignant mixed germ cell tumours of ovary. A Report of two cases.Int J Med Sci and Public Health201431105710.5455/ijmsph.2013.061020133

6 

B Tiwary H Sinha V Pandey Malignant mixed germ cell tumor of ovary: a rare case reportInt J Reprod Contracept Obstet Gynecol201542511310.5455/2320-1770.ijrcog20150450

7 

NC Moniaga LM Randall Malignant Mixed Ovarian Germ Cell Tumor with Embryonal ComponentJ Pediatr Adolesc Gynecol2011241e1e310.1016/j.jpag.2010.05.001

8 

HM Brammer JL Buck WS Hayes S Sheth FA Tavassoli From the archives of the AFIP. Malignant germ cell tumors of the ovary: radiologic-pathologic correlation.RadioGraphics19901047152410.1148/radiographics.10.4.2165627

9 

JS Berek N Hacker JS Berek NF Hacker Practical Gynecologic Oncology5th EditionWilliams and WilkinsPhiladelphia2007

10 

JB Jolinière NB Ali A Fadhlaoui JB Dubuisson L Guillou A Sutter Two Case Reports of a Malignant Germ Cell Tumor of Ovary and a Granulosa Cell Tumor: Interest of Tumoral Immunochemistry in the Identification and ManagementFront Oncol2014410.3389/fonc.2014.00097

11 

DT Trinh K Shibata T Hirosawa T Umezu M Mizuno H Kajiyama Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovaryJ Obstet Gynaecol Res2012385841810.1111/j.1447-0756.2011.01798.x

12 

CDM Fletcher Diagnostic histopathology of tumours13rd Edition199560415

13 

M Kawai T Kano Y Furuhashi T Misawa N Nakashima S Hattori Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 casesCancer199167118492Cacer

14 

RJ Kurman HJ Norris Embryonal carcinoma of the ovary.A clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testisCancer197638624203310.1002/1097-0142(197612)38:6<2420::aid-cncr2820380630>3.0.co;2-2

15 

JJH Low LC Perrin AJ Crandon NF Hacker Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumorsCancer2000892391810.1002/1097-0142(20000715)89:2<391::aid-cncr26>3.0.co;2-v

16 

N Murugaesu P Schmid G Dancey R Agarwal L Holden I McNeish Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality TreatmentJ Clin Oncol200624304862610.1200/jco.2006.06.2489

17 

S Kumar JP Shah CS Bryant AN Imudia ML Cote R Ali-fehmi The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovaryGynecol Oncol200811021253210.1016/j.ygyno.2008.04.022

18 

D Pectasides E Pectasides D Kassanos Germ cell tumors of the ovaryCancer Treat Rev20083454274110.1016/j.ctrv.2008.02.002



jats-html.xsl

© This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


  • Article highlights
  • Article tables
  • Article images

Article History

Received : 22-04-2021

Accepted : 23-06-2021

Available online : 13-08-2021


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijpo.2021.084


Article Metrics






Article Access statistics

Viewed: 139

PDF Downloaded: 75



Wiki in hindi